Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies.
作者信息
Bullock Timothy N J
机构信息
Department of Pathology, University of Virginia, Charlottesville, VA, USA.
出版信息
Cell Mol Immunol. 2022 Jul;19(7):866. doi: 10.1038/s41423-022-00865-2.
Abstract
摘要
相似文献
1
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies.更正：CD40刺激作为癌症疫苗和其他免疫疗法的分子佐剂。
Cell Mol Immunol. 2022 Jul;19(7):866. doi: 10.1038/s41423-022-00865-2.
2
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.在恒河猴中，将HIV-1包膜糖蛋白gp140靶向CD40与靶向凝集素样氧化低密度脂蛋白受体1（LOX-1）相比，并结合具有复制能力的NYVAC-KC，在诱导Env特异性抗体和T细胞反应方面的优势。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.01596-16. Print 2017 May 1.
3
RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy.RNA转染的CD40激活的B细胞诱导针对病毒和肿瘤抗原靶点的功能性T细胞反应：对儿科免疫治疗的意义。
Blood. 2004 Mar 15;103(6):2046-54. doi: 10.1182/blood-2003-07-2379. Epub 2003 Nov 20.
4
Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.肿瘤疫苗诱导的保护性免疫需要CD40与其配体CD154之间的相互作用。
Cancer Res. 1997 Jul 1;57(13):2569-74.
5
Agonistic anti-CD40 antibody therapy is effective against postoperative cancer recurrence and metastasis in a murine tumor model.激动性抗 CD40 抗体治疗在一种小鼠肿瘤模型中对术后癌症复发和转移有效。
J Immunother. 2013 Sep;36(7):365-72. doi: 10.1097/CJI.0b013e31829fb856.
6
The role of CD40 and CD154/CD40L in dendritic cells.CD40与CD154/CD40L在树突状细胞中的作用。
Semin Immunol. 2009 Oct;21(5):265-72. doi: 10.1016/j.smim.2009.05.010. Epub 2009 Jun 12.
7
Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation.CD40刺激后急性淋巴细胞白血病细胞中抗原加工机制成分在mRNA水平上的上调。
Ann Hematol. 2007 May;86(5):339-45. doi: 10.1007/s00277-007-0256-z. Epub 2007 Feb 7.
8
EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.EBV LMP1，一种模拟 CD40 的病毒，在被整合到 HIV 疫苗中时，可激活树突状细胞，并作为一种分子佐剂发挥作用。
J Leukoc Biol. 2011 Aug;90(2):389-98. doi: 10.1189/jlb.0211068. Epub 2011 May 17.
9
CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic.CD40 靶向腺病毒癌症疫苗：通往临床的漫长曲折之路。
J Gene Med. 2012 Jun;14(6):416-27. doi: 10.1002/jgm.1648.
10
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses.用抗神经/抗 CD40 偶联纳米颗粒靶向肿瘤微环境，诱导抗肿瘤免疫反应。
Vaccine. 2010 Feb 3;28(5):1383-90. doi: 10.1016/j.vaccine.2009.10.153. Epub 2009 Nov 18.
引用本文的文献
1
Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.类风湿关节炎中的异常 B 细胞激活和 B 细胞亚群：通过临床活动、自身抗体血清阳性和治疗进行分析。
Clin Exp Immunol. 2023 Dec 13;214(3):314-327. doi: 10.1093/cei/uxad076.
2
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell.重新思考抗原来源：基于全肿瘤细胞/组织裂解物或全肿瘤细胞的癌症疫苗。
Adv Sci (Weinh). 2023 Aug;10(22):e2300121. doi: 10.1002/advs.202300121. Epub 2023 May 31.
Zotero 插件